The effect of 5‐HT1A receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats. (6th May 2021)
- Record Type:
- Journal Article
- Title:
- The effect of 5‐HT1A receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats. (6th May 2021)
- Main Title:
- The effect of 5‐HT1A receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
- Authors:
- Vegas‐Suárez, Sergio
Aristieta, Asier
Requejo, Catalina
Bengoetxea, Harkaitz
Lafuente, José Vicente
Miguelez, Cristina
Ugedo, Luisa - Abstract:
- Abstract : Background and Purpose: l ‐DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5‐HT1A receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the etiopathology of l ‐DOPA‐induced dyskinesia, we investigated whether the entopeduncular nucleus is modulated by the 5‐HT1A receptor partial and full agonists, buspirone, and 8‐hydroxy‐2‐(di‐n‐propylamino)‐tetralin (8‐OH‐DPAT) in control and 6‐hydroxydopamine (6‐OHDA)‐lesioned rats with or without long‐term l ‐DOPA treatment. Experimental Approach: Extracellular single‐unit electrocorticogram and local field potential recordings under anaesthesia, immunostaining assays and optogenetic manipulation coupled to electrophysiological recordings were performed. Key Results: Systemic buspirone reduced the entopeduncular nucleus firing rate in the sham animals and burst activity in the 6‐OHDA‐lesioned rats (with or without l ‐DOPA treatment), while local administration reduced entopeduncular nucleus activity in all the groups, regardless of DA integrity. Systemic 8‐OH‐DPAT also induced inhibitory effects only in the sham animals. Effects triggered by buspirone and 8‐OH‐DPAT were reversed by the 5‐HT1A receptor antagonist, WAY‐100635. Neither buspirone nor 8‐OH‐DPAT modified the low‐frequency oscillatory activity in the entopeduncular nucleus or its synchronization with the motorAbstract : Background and Purpose: l ‐DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5‐HT1A receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the etiopathology of l ‐DOPA‐induced dyskinesia, we investigated whether the entopeduncular nucleus is modulated by the 5‐HT1A receptor partial and full agonists, buspirone, and 8‐hydroxy‐2‐(di‐n‐propylamino)‐tetralin (8‐OH‐DPAT) in control and 6‐hydroxydopamine (6‐OHDA)‐lesioned rats with or without long‐term l ‐DOPA treatment. Experimental Approach: Extracellular single‐unit electrocorticogram and local field potential recordings under anaesthesia, immunostaining assays and optogenetic manipulation coupled to electrophysiological recordings were performed. Key Results: Systemic buspirone reduced the entopeduncular nucleus firing rate in the sham animals and burst activity in the 6‐OHDA‐lesioned rats (with or without l ‐DOPA treatment), while local administration reduced entopeduncular nucleus activity in all the groups, regardless of DA integrity. Systemic 8‐OH‐DPAT also induced inhibitory effects only in the sham animals. Effects triggered by buspirone and 8‐OH‐DPAT were reversed by the 5‐HT1A receptor antagonist, WAY‐100635. Neither buspirone nor 8‐OH‐DPAT modified the low‐frequency oscillatory activity in the entopeduncular nucleus or its synchronization with the motor cortex. Buspirone did not alter the response induced by subthalamic nucleus opto‐stimulation in the entopeduncular nucleus. Conclusion and Implications: Systemic 5‐HT1A receptor activation elicits different effects on the electrophysiological properties of the entopeduncular nucleus depending on the integrity of the nigrostriatal pathway and it does not alter the relationship between subthalamic nucleus and entopeduncular nucleus neuron activity. … (more)
- Is Part Of:
- British journal of pharmacology. Volume 178:Number 12(2021)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 178:Number 12(2021)
- Issue Display:
- Volume 178, Issue 12 (2021)
- Year:
- 2021
- Volume:
- 178
- Issue:
- 12
- Issue Sort Value:
- 2021-0178-0012-0000
- Page Start:
- 2516
- Page End:
- 2532
- Publication Date:
- 2021-05-06
- Subjects:
- 8‐OH‐DPAT -- basal ganglia -- buspirone -- dyskinesia -- electrophysiology -- Parkinson's disease -- 5‐hyroxytryptamine -- serotonin
Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.15437 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23599.xml